secwatch / observer
8-K filed May 25, 2023, 7:59 PM ET ticker BDSX CIK 0001439725
other confidence high sentiment neutral materiality 0.15

Biodesix stockholders elect three directors, ratify KPMG, approve option exchange at 2023 annual meeting

BIODESIX INC

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIODESIX INC shareholders approved Election of three Class III director nominees to serve until the 2026 annual meeting of stockholders. at the 2023-05-23 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-23
Exact text from the filing
1. At the Annual Meeting, the Company’s stockholders elected, by the vote indicated below, the following three persons as the Class III directors of the Company, each to serve until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualify: Name Votes For Votes Against Abstentions Broker Non-Votes Jean Franchi 62,297,395 0 2,321,345 6,913,414 Hany Massarany 61,373,077 0 3,245,663 6,913,414 Jack Schuler 62,235,368 0 2,383,372 6,913,414
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIODESIX INC shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. at the 2023-05-23 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-23
Exact text from the filing
2. At the Annual Meeting, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, by the vote indicated below: Votes For Votes Against Abstentions Broker Non-Votes 71,408,435 95,555 28,164 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIODESIX INC shareholders approved Approval of the stock option exchange program. at the 2023-05-23 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-05-23
Exact text from the filing
3. At the Annual Meeting, the stockholders approved the stock option exchange program by the vote indicated below: Votes For Votes Against Abstentions Broker Non-Votes 60,434,183 4,164,987 19,570 6,913,414
View on SEC.gov

Browse all shareholder votes →

BIODESIX INC filing history →

Source: SEC EDGAR
accession 0001193125-23-154219
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.